Amarin

$4.98
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.20%) Today

-$0.04 (-0.80%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Amarin and other stocks, options, and ETFs commission-free!

About AMRN

Amarin Corporation plc, also called Amarin, is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids.

CEO

John F. Thero

Employees

1,000

Headquarters

Dublin, Dublin

Founded

1989

Market Cap

2.26B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

7.47M

High Today

$5.07

Low Today

$4.86

Open Price

$5.04

Volume

4.41M

52 Week High

$9.25

52 Week Low

$3.36

AMRN News

BenzingaApr 13

The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 12) 180 Life

Analyst Ratings

56%

of 9 ratings

Buy

56%

Hold

44%

Sell

AMRN Earnings

-$0.07

-$0.04

-$0.01

$0.02

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected Apr 27, After Hours